38 results on '"Kubota, Hirohito"'
Search Results
2. HOIL-1L deficiency induces cell cycle alteration which causes immaturity of skeletal muscle and cardiomyocytes
3. Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases
4. Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia
5. RNA-seq–based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia
6. Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
7. A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
8. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia
9. Successful cord blood transplantation using reduced intensity conditioning in a 5‐month‐old patient with IL‐10RA deficiency.
10. HOIL-1L deficiency induces cell cycle alteration which causes immaturity of myocyte and fibrogenesis
11. High‐dose carboplatin–irinotecan–temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma
12. Corrigendum to “Chlorambucil-conjugated PI-polyamide (Chb-M’), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation” [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150–157]
13. RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
14. The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models
15. PAX5 alterations in an infant case of KMT2A ‐rearranged leukemia with lineage switch
16. Use of Cabozantinib to Treat MET-amplified Pediatric Colorectal Cancer
17. Use of Cabozantinib to Treat MET -amplified Pediatric Colorectal Cancer.
18. Chimeric antigen receptor T‐cell therapy for a patient with Philadelphia chromosome‐positive acute lymphoblastic leukemia and leukoencephalopathy who relapsed after bone marrow transplantation
19. Inotuzumab ozogamicin is an effective treatment for CD22-positive acute undifferentiated leukemia: A case report
20. Immature teratoma of the ovary associated with Cowden syndrome
21. RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
22. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia
23. Mass Cytometric Analysis Revealed Dynamic Alteration of the Tumor Immune Environment in Bone Marrow from Children with Recurrent B Cell Precursor Acute Lymphoblastic Leukemia
24. RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
25. Inotuzumabozogamicin is an effective treatment for CD22‐positive acute undifferentiated leukemia: A case report
26. Suppression of malignant rhabdoid tumors through Chb‐M′‐mediated RUNX1 inhibition
27. RUNX-NFAT Axis As a Novel Therapeutic Target for AML and T Cell Immunity
28. Gastric ulcer and gastroenteritis caused by Epstein–Barr virus during immunosuppressive therapy for a child with systemic juvenile idiopathic arthritis
29. RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
30. Therapeutic Targeting of RUNX-NFATC2 Axis for Acute Promyelocytic Leukemia and T Cell Immunity
31. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.
32. Immature teratoma of the ovary associated with Cowden syndrome.
33. Suppression of malignant rhabdoid tumors through Chb‐M′‐mediated RUNX1 inhibition.
34. High-dose chemotherapy with autologous stem cell transplantation spares re-irradiation for recurrent intracranial germinoma
35. Monocyte Chemoattractant Protein-1 (MCP-1) as a Potential Therapeutic Target and a Noninvasive Biomarker of Liver Fibrosis Associated With Transient Myeloproliferative Disorder in Down Syndrome
36. Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
37. Efficacy of off-the-shelf bone marrow mesenchymal stem cells for pediatric steroid-refractory acute graft-versus-host disease.
38. [Pediatric acute lymphoblastic leukemia presenting with bone and joint pain].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.